Fenimore Christopher R.'s Form 4/A amendment
AmendedRegeneron Pharmaceuticals, Inc. (REGN) · filed Aug 25, 2021
- Accession no.
- 0001104659-21-109328
- Filed
- Aug 25, 2021
- Trade date
- Aug 20, 2021
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Aug 24, 2021
This filing lists 1 non-derivative transaction. It carries over 9 transactions from the original filing that it did not restate. Open-market sales total $3.13M. It was filed 5 days after the trade.
This amendment restates part of 0001237899-21-000017 (filed Aug 24, 2021). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Fenimore Christopher R.CIK 0001697422 | Officer (SVP Controller) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 20, 2021 | Common Stock | FTax withholdingDisposed | −8,719 | $664.85 | −$5,796,827.15 | 19,020 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001237899-21-000017 (filed Aug 24, 2021).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 20, 2021 | Common Stock | MOption exerciseAcquired | +13,500 | $179.13 | +$2,418,255 | 32,520 | Direct | |
| Aug 23, 2021 | Common Stock | SSaleDisposed | −4,576 | $655.00 | −$2,997,280 | 27,944 | Direct | |
| Aug 23, 2021 | Common Stock | SSaleDisposed | −9 | $659.33F2 | −$5,933.97 | 27,935 | Direct | |
| Aug 23, 2021 | Common Stock | SSaleDisposed | −23 | $660.33F3 | −$15,187.59 | 27,912 | Direct | |
| Aug 23, 2021 | Common Stock | SSaleDisposed | −88 | $661.89F4 | −$58,246.32 | 27,824 | Direct | |
| Aug 23, 2021 | Common Stock | SSaleDisposed | −1 | $662.78 | −$662.78 | 27,823 | Direct | |
| Aug 23, 2021 | Common Stock | SSaleDisposed | −70 | $663.05F5 | −$46,413.5 | 27,753 | Direct | |
| Aug 23, 2021 | Common Stock | SSaleDisposed | −14 | $665.21 | −$9,312.94 | 27,739 | Direct |
Derivative securities (Table II)
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 20, 2021 | Common Stock | MOption exerciseDisposed | −13,500 | $0.00 | $0 | 0 | Direct |
Footnotes on the original
The footnotes that the prices of these transactions refer to on the original filing.
- F2
Represents volume-weighted average price of sales of 9 shares of Company stock on August 23, 2021 at prices ranging from $659.28 to $659.45. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2021 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents volume-weighted average price of sales of 23 shares of Company stock on August 23, 2021 at prices ranging from $660.09 to $660.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2021 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents volume-weighted average price of sales of 88 shares of Company stock on August 23, 2021 at prices ranging from $661.47 to $661.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2021 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents volume-weighted average price of sales of 70 shares of Company stock on August 23, 2021 at prices ranging from $663.00 to $663.13. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2021 at each separate price.
Referenced by the price of 1 transaction in Table I.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- F2
The amount of securities shown following the reported transaction gives effect to the other transactions reported by the Reporting Person in the Original Form 4.
Remarks
This Form 4/A amends the Form 4 filed by the Reporting Person on August 24, 2021 (the "Original Form 4") by adding a transaction inadvertently omitted from the Original Form 4.